|
2013 Journal Article A differential impact of mycophenolic acid, prednisolone, and tacrolimus exposure on scd30 levels in adult kidney transplant recipientsBarraclough, Katherine A., Staatz, Christine E., Johnson, David W., Gillis, David, Lee, Katie J., McWhinney, Brett C., Ungerer, Jacobus P. J., Campbell, Scott B. and Isbel, Nicole M. (2013). A differential impact of mycophenolic acid, prednisolone, and tacrolimus exposure on scd30 levels in adult kidney transplant recipients. Therapeutic Drug Monitoring, 35 (2), 240-245. doi: 10.1097/FTD.0b013e31828286dd |
|
2013 Journal Article Population pharmacokinetics of tobramycin in patients with and without cystic fibrosisHennig, Stefanie, Standing, Joseph F., Staatz, Christine E. and Thomson, Alison H. (2013). Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis. Clinical Pharmacokinetics, 52 (4), 289-301. doi: 10.1007/s40262-013-0036-y |
|
2013 Journal Article Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting Dose.Bergman, Troels K., Hennig, Stefanie, Barraclough, Katherine A., Isbe,l Nicole M. and Staatz, Christine E. (2013). Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting Dose.. Therapeutic Drug Monitoring, 36 (1), 62-70. doi: 10.1097/FTD.0b013e31829f1ab8 |
|
2012 Journal Article NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantationBarraclough, Katherine A., Isbel, Nicole M., Lee, Katie J., Bergmann, Troels K., Johnson, David W., McWhinney, Brett C., Ungerer, Jacobus P. J., Campbell, Scott B., Leary, Diana R., Bialasiewicz, Seweryn, Rockett, Rebecca J. and Staatz, Christine E. (2012). NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation. Transplantation, 94 (10), 1025-1032. doi: 10.1097/TP.0b013e31826c3985 |
|
2012 Journal Article Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first weekBarraclough, Katherine A., Staatz, Christine E., Johnson, David W., Lee, Katie J., McWhinney, Brett C., Ungerer, Jacobus P. J., Hawley, Carmel M., Campbell, Scott B., Leary, Diana R. and Isbel, Nicole M. (2012). Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week. Transplant International, 25 (11), 1182-1193. doi: 10.1111/j.1432-2277.2012.01553.x |
|
2012 Journal Article A limited sampling strategy for the simultaneous estimation of tacrolimus, mycophenolic acid and unbound prednisolone exposure in adult kidney transplant recipientsBarraclough, Katherine A., Isbel, Nicole M., Johnson, David W., Hawley, Carmel M., Lee, Katie J., Mcwhinney, Brett C., Ungerer, Jacobus P., Campbell, Scott B., Leary, Diana R. and Staatz, Christine E. (2012). A limited sampling strategy for the simultaneous estimation of tacrolimus, mycophenolic acid and unbound prednisolone exposure in adult kidney transplant recipients. Nephrology, 17 (3), 294-299. doi: 10.1111/j.1440-1797.2011.01560.x |
|
2012 Journal Article Continuous infusion vs. bolus dosing: Implications for beta-lactam antibioticsAbdul-Aziz, Mohd Hafiz, Staatz, C. E., Kirkpatrick, C. M. J., Lipman, J. and Roberts, J. A. (2012). Continuous infusion vs. bolus dosing: Implications for beta-lactam antibiotics. Minerva Anestesiologica, 78 (1), 94-104. |
|
2012 Journal Article Clinical Pharmacokinetics and Pharmacodynamics of Prednisolone and Prednisone in Solid Organ TransplantationBergmann, Troels K., Barraclough, Katherine A., Lee, Katie J. and Staatz, Christine E. (2012). Clinical Pharmacokinetics and Pharmacodynamics of Prednisolone and Prednisone in Solid Organ Transplantation. Clinical Pharmacokinetics, 51 (11), 711-741. doi: 10.1007/s40262-012-0007-8 |
|
2011 Journal Article Population pharmacokinetics of tacrolimus in pediatric liver transplantation: Early posttranplantation clearanceWallin, Johan E., Bergstrand, Martin, Wilczek, Henryk E., Nydert, Per S., Karlsson, Mats O. and Staatz, Christine E. (2011). Population pharmacokinetics of tacrolimus in pediatric liver transplantation: Early posttranplantation clearance. Therapeutic Drug Monitoring, 33 (6), 663-672. doi: 10.1097/FTD.0b013e31823415cc |
|
2011 Journal Article Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?Staatz, Christine E. and Tett, Susan E. (2011). Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?. Clinical Pharmacokinetics, 50 (12), 759-772. doi: 10.2165/11596380-000000000-00000 |
|
2011 Journal Article Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipientsBarraclough, Katherine A, Isbel, Nicole M., McWhinney, Brett C., Ungerer, Jacobus P. J., Medley, Gregory, Johnson, David W., Hawley, Carmel M., Leary, Diana R., Campbell, Scott B. and Staatz, Christine E. (2011). Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients. European Journal of Clinical Pharmacology, 67 (12), 1243-1252. doi: 10.1007/s00228-011-1071-y |
|
2011 Journal Article Once- versus twice-daily tacrolimus: Are the formulations truly equivalent?Barraclough, Katherine A, Isbel, Nicole M., Johnson, David W., Campbell, Scott B. and Staatz, Christine E. (2011). Once- versus twice-daily tacrolimus: Are the formulations truly equivalent?. Drugs, 71 (12), 1561-1577. doi: 10.2165/11593890-000000000-00000 |
|
2011 Journal Article Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposureTett, Susan E., Saint-Marcoux, Franck, Staatz, Christine E., Brunet, Merce, Vinks, Alexander A., Miura, Masatomo, Marquet, Pierre, Kuypers, Dirk R., van Gelder, Teun and Cattaneo, Dario (2011). Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. Transplantation Reviews, 25 (2), 47-57. doi: 10.1016/j.trre.2010.06.001 |
|
2011 Journal Article Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipientsBarraclough, KA, Isbel, NM, Kirkpatrick, CM, Lee, KJ, Taylor, PJ, Johnson, DW, Campbell, SB, Leary, DR and Staatz, CE (2011). Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients. British Journal of Clinical Pharmacology, 71 (2), 207-223. doi: 10.1111/j.1365-2125.2010.03815.x |
|
2011 Journal Article BK virus in kidney transplant recipients: The influence of immunosuppressionBarraclough, Katherine A, Isbel, Nicole M., Staatz, Christine E. and Johnson, David W. (2011). BK virus in kidney transplant recipients: The influence of immunosuppression. Journal of Transplantation, 2011 (1) 750836, Article ID 750836-9. doi: 10.1155/2011/750836 |
|
2010 Journal Article Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipientsBarraclough, Katherine A., Isbel, Nicole M., Franklin, Michael E., Lee, Katie J., Taylor, Paul J., Campbell, Scott B., Petchey, William G. and Staatz, Christine E. (2010). Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients. Therapeutic Drug Monitoring, 32 (6), 723-733. doi: 10.1097/FTD.0b013e3181fc8fbb |
|
2010 Journal Article Pharmacodynamic monitoring of immunosuppression in kidney transplantationBarraclough, Katherine A., Staatz, Christine E., Isbel, Nicole M. and McTaggart, Steven J. (2010). Pharmacodynamic monitoring of immunosuppression in kidney transplantation. Nephrology, 15 (5), 522-532. doi: 10.1111/j.1440-1797.2010.01349.x |
|
2010 Journal Article Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and opticept trialsBarraclough, KA, Isbel, NM and Staatz, CE (2010). Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and opticept trials. Transplantation, 90 (1), 44-51. doi: 10.1097/TP.0b013e3181e06584 |
|
2010 Journal Article Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part IIStaatz, Christine E., Goodman, Lucy K. and Tett, Susan E. (2010). Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II. Clinical Pharmacokinetics, 49 (4), 207-221. doi: 10.2165/11317550-000000000-00000 |
|
2010 Journal Article Pharmacogenetic influences on mycophenolate therapyBarraclough, Katherine A., Lee, Katie J. and Staatz, Christine E. (2010). Pharmacogenetic influences on mycophenolate therapy. Pharmacogenomics, 11 (3), 369-390. doi: 10.2217/PGS.10.9 |
